GLP-1 agonist Victoza to be discontinued The liraglutide injection will not be returning to the market after its extended period out of stock, Novo Nordisk has confirmed
Exenatide, an exogenous GLP-1RA, has been shown to enhance hypothalamic connectivity in obese individuals who respond to its anorexigenic effects, while also decreasing food reward-related brain activation
the meds may have a bit of a crash if you stop taking them
Hormonal fluctuations during the menstrual cycle can influence GI symptoms, with some women noticing that semaglutide side effects are worse during certain phases of their cycle
William Seeds, MD, a board certified orthopedic surgeon and the owner of Redox Medical Group, was enthusiastic about the findings of the study
Bornhvd C, Vogel F, Neupert W, Reichert AS